Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/38316

Title:	Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.
Authors:	Bermejo, Javier Yotti, Raquel García-Orta, Rocío Sánchez-Fernández, Pedro L Castaño, Mario Segovia-Cubero, Javier Escribano-Subías, Pilar San Román, José Alberto Borrás, Xavier Alonso-Gómez, Angel Botas, Javier Crespo-Leiro, María G Velasco, Sonia Bayés-Genís, Antoni López, Amador Muñoz-Aguilera, Roberto de Teresa, Eduardo González-Juanatey, José R Evangelista, Arturo Mombiela, Teresa González-Mansilla, Ana Elízaga, Jaime Martín-Moreiras, Javier González-Santos, José M Moreno-Escobar, Eduardo Fernández-Avilés, Francisco View more
Issue Date:	14-Apr-2018
Citation:	Eur. Heart J..2018 Apr;(39)15:1255-1264
Abstract:	We aimed to determine whether treatment with sildenafil improves outcomes of patients with persistent pulmonary hypertension (PH) after correction of valvular heart disease (VHD).
PMID:	29281101
URI:	https://hdl.handle.net/20.500.12530/38316
Rights:	openAccess
Appears in Collections:	Hospitales > H. U. Fundación Alcorcón > Artículos Fundaciones e Institutos de Investigación > IIS H. General U. Gregorio Marañón > Artículos Hospitales > H. U. Infanta Leonor > Artículos

Files in This Item:

File	Description	Size	Format
PMC5905634.pdf		767.66 kB	Adobe PDF	View/Open